Star adds $200M after spinout successes

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 23 Oct, 11:00 UTC

Following exits for its subsidiaries Electra Therapeutics and Vega Therapeutics, Star is now mining for a new drug prospect.

science

Sources

• T2Star adds $200M after spinout successesBioPharma Dive / Healthcare Dive / MedTech Dive23 Oct, 11:00